Hormone therapy study could unlock kidney disease secrets
NCT ID NCT07542964
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how sex hormones from gender-affirming therapy change kidney function. Researchers will measure kidney performance, blood flow, and insulin sensitivity in 60 transgender people before and after one year of hormone treatment. The goal is to understand why men and women have different rates of kidney disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal why men and women have different risks for kidney disease, potentially guiding future treatments.
- What could go wrong
- This is an early observational study with only 60 participants, so findings may not apply broadly. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC, location VU medical centre, internal medicine
Amsterdam, North Holland, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your bone health decide if a dental implant lasts?
- Can a simple foot pump ease leg swelling in hospital patients?
- Could your blood type predict kidney treatment success?
- Can community hospitals in zambia master severe disease care?
- Could a pill shield the brain and kidneys during heart surgery?
- Can an ancient herbal remedy soothe the aftermath of stone surgery?